1 |
Weng ZK, Lin TH, Chang KH, Chiu YJ, Lin CH, Tseng PH, Sun YC, Lin W, Lee-Chen GJ, Chen CM. Using ΔK280 Tau(RD) Folding Reporter Cells to Screen TRKB Agonists as Alzheimer's Disease Treatment Strategy. Biomolecules 2023;13. [PMID: 36830589 DOI: 10.3390/biom13020219] [Reference Citation Analysis]
|
2 |
Lin T, Chang K, Chiu Y, Weng Z, Sun Y, Lin W, Lee-chen G, Chen C. Neuroprotective Action of Coumarin Derivatives through Activation of TRKB-CREB-BDNF Pathway and Reduction of Caspase Activity in Neuronal Cells Expressing Pro-Aggregated Tau Protein. IJMS 2022;23:12734. [DOI: 10.3390/ijms232112734] [Reference Citation Analysis]
|
3 |
Chiu YJ, Lin TH, Chang KH, Lin W, Hsieh-Li HM, Su MT, Chen CM, Sun YC, Lee-Chen GJ. Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect Aβ-GFP SH-SY5Y cells against Aβ toxicity. Aging (Albany NY) 2022;14:7568-86. [PMID: 36170028 DOI: 10.18632/aging.204306] [Reference Citation Analysis]
|
4 |
Liu W, Wu L, Liu W, Tian L, Chen H, Wu Z, Wang N, Liu X, Qiu J, Feng X, Xu Z, Jiang X, Zhao Q. Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease. Eur J Med Chem 2022;242:114689. [PMID: 36007469 DOI: 10.1016/j.ejmech.2022.114689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|